TEMA ONCOLOGY ETF (CANC) Institutional Ownership and Insiders Activity

TEMA ONCOLOGY ETF (CANC) is widely held by institutional investors, with 14 firms reporting positions valued at approximately $23.97M based on SEC Form 13F filings for the quarter ended June 30, 2026.

Thrivent Financial For Lutherans is the largest disclosed holder, reporting approximately $7.67M in CANC holdings in its latest filing.